DexCom

Forecast & Rating29 analysts currently cover DexCom, with about 86.2% giving a positive rating — meaning they expect the stock to rise. The average price target is $86.16, about 15.6% upside from the current price of $74.54. Price targets range from $65.00 to $112.00 — a wide spread, showing clear disagreement over just how much DexCom can rise. Historically, about 59.3% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study DexCom closely still see room for the stock to rise. Data as of Jul 28, 2026; for reference only and not investment advice.